Trainings

Trainings

Protecting Human Research Participants

URL 1: https://phrp.nihtraining.com/index.php

Date Developed: 2008. Source: National Institutes of Health. Presenter(s): n/a. Type: Online Course. Level: Intermediate Advanced. Length: 180 minutes.

Annotation

This course is intended for use by individuals pursuing human subject research. It includes 7 modules and 4 quizzes. Topics addressed include the history of human subject participation, including War Crimes, and the Tuskegee Syphilis Study, the three ethical principles made in the Belmont Report, and the informed consent process. Justice, equity and special group consent also are covered, as are risks and benefits of participatory research, the role of Institutional Review Boards (IRB), and clinical trial requirements . The course has been retired as of Sept. 28, 2018; archival materials are available as a reference.

Learning Objectives

• Describe the history and importance of human subjects protections.

• Identify research activities that involve human subjects.

• Discover the risks a research project might pose to participants.

• Understand how to minimize the risks posed by a research project.

• Describe additional protections needed for vulnerable populations.

• Understand additional issues that should be considered for international research.

• Describe appropriate procedures for recruiting research participants and obtaining informed consent.

• Identify the different committees that monitor human subjects protections.

• Understand the importance of study design in the protection of research participants.

Special Instructions

Registration is required then click on "Registration".

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number UE8MC25742; MCH Navigator for $180,000/year. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.